Chemical Formula: C29H38O4

Chemical Formula C29H38O4

Found 31 metabolite its formula value is C29H38O4

Celastrol

2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)-

C29H38O4 (450.2769948)


Celastrol, a plant-derived triterpene, has antioxidant and anti-inflammatory activity that may prevent neuronal degeneration in Alzheimers disease (AD). In the brains of patients with AD signs of neuronal degeneration are accompanied by markers of microglial activation, inflammation, and oxidant damage. The presence of nitrotyrosine in the cell bodies of neurons in AD suggests that peroxynitrite contributes to the pathogenesis of the disease. In low nanomolar concentrations celastrol was found to suppress the production by human monocytes and macrophages of the pro-inflammatory cytokines TNF-alpha and IL-1beta. Celastrol also decreased the induced expression of class II MHC molecules by microglia. In macrophage lineage cells and endothelial cells celastrol decreased induced but not constitutive NO production. Celastrol suppresses adjuvant arthritis in the rat, demonstrating in vivo anti-inflammatory activity. Low doses of celastrol administered to rats significantly improved their performance in memory, learning and psychomotor activity tests. The potent antioxidant and anti-inflammatory activities of celastrol, and its effects on cognitive functions, suggest that the drug may be useful to treat neurodegenerative diseases accompanied by inflammation, such as AD. (PMID: 11513350) [HMDB] Celastrol, a plant-derived triterpene, has antioxidant and anti-inflammatory activity that may prevent neuronal degeneration in Alzheimers disease (AD). In the brains of patients with AD signs of neuronal degeneration are accompanied by markers of microglial activation, inflammation, and oxidant damage. The presence of nitrotyrosine in the cell bodies of neurons in AD suggests that peroxynitrite contributes to the pathogenesis of the disease. In low nanomolar concentrations celastrol was found to suppress the production by human monocytes and macrophages of the pro-inflammatory cytokines TNF-alpha and IL-1beta. Celastrol also decreased the induced expression of class II MHC molecules by microglia. In macrophage lineage cells and endothelial cells celastrol decreased induced but not constitutive NO production. Celastrol suppresses adjuvant arthritis in the rat, demonstrating in vivo anti-inflammatory activity. Low doses of celastrol administered to rats significantly improved their performance in memory, learning and psychomotor activity tests. The potent antioxidant and anti-inflammatory activities of celastrol, and its effects on cognitive functions, suggest that the drug may be useful to treat neurodegenerative diseases accompanied by inflammation, such as AD. (PMID: 11513350). Celastrol is a pentacyclic triterpenoid that is 24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid bearing an oxo substituent at position 2, a hydroxy substituent at position 3 and two methyl groups at positions 9 and 13. An antioxidant and anti-inflammatory agent. Potently inhibits lipid peroxidation in mitochondria and inhibits TNF-alpha-induced NFkappaB activation. Also shown to inhibit topoisomerase II activity in vitro (IC50 = 7.41 muM). It has a role as an antioxidant, an anti-inflammatory drug, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, an antineoplastic agent, a Hsp90 inhibitor and a metabolite. It is a pentacyclic triterpenoid and a monocarboxylic acid. Celastrol is a natural product found in Reissantia buchananii, Crossopetalum gaumeri, and other organisms with data available. A pentacyclic triterpenoid that is 24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid bearing an oxo substituent at position 2, a hydroxy substituent at position 3 and two methyl groups at positions 9 and 13. An antioxidant and anti-inflammatory agent. Potently inhibits lipid peroxidation in mitochondria and inhibits TNF-alpha-induced NFkappaB activation. Also shown to inhibit topoisomerase II activity in vitro (IC50 = 7.41 muM).

   
   

3-Me ether-2,3-Dihydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|3-methyl-6-oxo-tingenol|3-O-methyl-6-oxotingenol

3-Me ether-2,3-Dihydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|3-methyl-6-oxo-tingenol|3-O-methyl-6-oxotingenol

C29H38O4 (450.2769948)


   

18-O-(Z)-p-coumaroylbeyer-15-ene-11beta,18-diol|obtsurin D

18-O-(Z)-p-coumaroylbeyer-15-ene-11beta,18-diol|obtsurin D

C29H38O4 (450.2769948)


   

(Z)-Cinnamoyl-(ent-13E)-15-Hydroxy-1(10),13-halimadien-18-oic acid

(Z)-Cinnamoyl-(ent-13E)-15-Hydroxy-1(10),13-halimadien-18-oic acid

C29H38O4 (450.2769948)


   
   
   

Celastrol

(2R,4aS,6aS,6aR,14aS,14bR)-10-hydroxy-11-keto-2,4a,6a,6a,9,14a-hexamethyl-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

C29H38O4 (450.2769948)


   

22beta-hydroxy-6-oxotingenol

22beta-hydroxy-6-oxotingenol

C29H38O4 (450.2769948)


   

wilforol B

wilforol B

C29H38O4 (450.2769948)


A pentacyclic triterpenoid with formula C29H38O4, originally isolated from the root bark of Tripterygium wilfordii.

   

25(9>8),26(13->14)abeo-24-nor-8,14-seco-friedelan-2,3-dihydroxy-1,3,5(10),6,8-pentaen-29(13)-olide

25(9>8),26(13->14)abeo-24-nor-8,14-seco-friedelan-2,3-dihydroxy-1,3,5(10),6,8-pentaen-29(13)-olide

C29H38O4 (450.2769948)


   

25(9->8)abeo-24-nor-8,14-seco-friedelan-2,3-dihydroxy-1,3,5(10),6,8,14(27)-hexaen-29-oic acid

25(9->8)abeo-24-nor-8,14-seco-friedelan-2,3-dihydroxy-1,3,5(10),6,8,14(27)-hexaen-29-oic acid

C29H38O4 (450.2769948)


   
   
   

2-hydroxy-3-methyl-21-oxo-12,24-dinor-D:B-friedoleane-1,3,5(10),7-tetraen-29-oic acid|rel-(2R,4aR,6aR,12bR,13aR,13bS)-2,3,4,4a,5,6,6a,8,12b,13,13a,13b-dodecahydro-11-hydroxy-2,4a,6a,9,10,12b,13a-heptamethyl-3-oxo-1H-dibenzo[a,i]fluorene-2-carboxylic acid

2-hydroxy-3-methyl-21-oxo-12,24-dinor-D:B-friedoleane-1,3,5(10),7-tetraen-29-oic acid|rel-(2R,4aR,6aR,12bR,13aR,13bS)-2,3,4,4a,5,6,6a,8,12b,13,13a,13b-dodecahydro-11-hydroxy-2,4a,6a,9,10,12b,13a-heptamethyl-3-oxo-1H-dibenzo[a,i]fluorene-2-carboxylic acid

C29H38O4 (450.2769948)


   

FAHFA 10:3/O-19:6

FAHFA 10:3/O-19:6

C29H38O4 (450.2769948)


   

FAHFA 11:3/O-18:6

FAHFA 11:3/O-18:6

C29H38O4 (450.2769948)


   

FAHFA 12:4/O-17:5

FAHFA 12:4/O-17:5

C29H38O4 (450.2769948)


   

FAHFA 13:4/O-16:5

FAHFA 13:4/O-16:5

C29H38O4 (450.2769948)


   

FAHFA 14:4/O-15:5

FAHFA 14:4/O-15:5

C29H38O4 (450.2769948)


   

FAHFA 15:5/O-14:4

FAHFA 15:5/O-14:4

C29H38O4 (450.2769948)


   

FAHFA 16:5/O-13:4

FAHFA 16:5/O-13:4

C29H38O4 (450.2769948)


   

FAHFA 17:5/O-12:4

FAHFA 17:5/O-12:4

C29H38O4 (450.2769948)


   

FAHFA 18:6/O-11:3

FAHFA 18:6/O-11:3

C29H38O4 (450.2769948)


   

FAHFA 19:6/O-10:3

FAHFA 19:6/O-10:3

C29H38O4 (450.2769948)